论文信息 - The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria. - 字舞流文

The Terminal Complement Inhibitor Eculizumab Reduces Thrombosis in Patients with Paroxysmal Nocturnal Hemoglobinuria.

N. Young | L. Luzzatto | J. Szer | U. Dührsen | A. Risitano | R. Brodsky | H. Schrezenmeier | G. Socié | J. Schubert | R. Rother | P. Muus | P. Hillmen | S. Rollins | A. Hill | L. Bell